Evidence map›Paper›PMID 24595035›Full record

ArticlePLoS medicine2014

Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco.

Albert Liu, Stephanie Cohen, Stephen Follansbee, Deborah Cohan, Shannon Weber, Darpun Sachdev, Susan Buchbinder

Registry-linked trialAbstract read
In one paragraph

Article in PLoS medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03617874 (PC4PrEP), which is not on this map. Cited by 153 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
153citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03617874 nacompletednot on this mapstarted 2020, after this paper: background citation

PC4PrEP: Integrating Pre-Exposure Prophylaxis (PrEP) Into Primary Care

TypeinterventionalSponsorAlbert Einstein College of MedicineRan2020 to 2022Enrolled22ConditionsHuman Immunodeficiency Virus TransmissionArmsPC4PrEP- Intervention Clinics, Standard of Care Clinics
3 · Its place in the literature

Who cites it

153 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

93 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Albert LiuBridge HIV, San Francisco Department of Public Health, San Francisco, California, United States of America; Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America.
Stephanie CohenDepartment of Medicine, University of California, San Francisco, San Francisco, California, United States of America; STD Prevention and Control, San Francisco Department of Public Health, San Francisco, California, United States of America.
Stephen FollansbeeKaiser Permanente Medical Center, San Francisco, California, United States of America.
Deborah CohanDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, California, United States of America.
Shannon WeberDepartment of Family and Community Medicine, University of California, San Francisco, San Francisco, California, United States of America.
Darpun SachdevBridge HIV, San Francisco Department of Public Health, San Francisco, California, United States of America; Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America.
Susan BuchbinderBridge HIV, San Francisco Department of Public Health, San Francisco, California, United States of America; Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, United States of America.

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Sheri Ann Lippman · 2001 to 2026
$57.4M
San Francisco Vaccine and Prevention UnitUM1AI069496 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI Susan Buchbinder, Diane V Havlir · 2012 to 2026
$30.5M
TRAINEESHIPS IN AIDS PREVENTION STUDIEST32MH019105 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Carol Suzanne Camlin, Glenn-Milo Santos · 1989 to 2026
$15.3M
Enhancing PrEP in Community Settings (EPIC)R01MH095628 · NIMH · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI LIU, ALBERT YING-HWA · 2011 to 2015
$2.4M
NIAID NIH HHS P30 AI027763NIAID NIH HHS UM1 AI069496NIMH NIH HHS P30 MH062246NIMH NIH HHS R01 MH095628NIMH NIH HHS T32 MH019105
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disease ManagementAdenineAnti-HIV AgentsDeoxycytidineEmtricitabineFemaleHIV InfectionsHumansMaleOrganophosphonatesSan FranciscoTenofovirAdenineAnti-HIV AgentsDeoxycytidineEmtricitabineOrganophosphonatesTenofovir

Identifiers

PMID24595035
PMCPMC3942317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.